TrialNeurology(R) neuroimmunology & neuroinflammation2022

Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral Sclerosis.

Jason R Thonhoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.